About Alidad Mireskandari

Experienced Chief Executive Officer with a demonstrated history of working in the molecular diagnostic industry. Expert in product development on NGS and microRNA platforms; strong background CAP/CLIA lab operations and FDA regulatory requirements. Skilled in Risk Management, Hedge Funds, Marketing Strategy, Private Equity, and Investments. Strong business development professional with a Ph.D. in Genetics and Master of Business Administration (MBA) focused in Finance from University of Michigan.